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♦ Background: In recent years, the rate of peritonitis
during continuous ambulatory peritoneal dialysis (CAPD)
has been significantly reduced. However, peritonitis re-
mains a major complication of CAPD, accounting for con-
siderable mortality and hospitalization among CAPD
patients.
♦ Objective: To generate a “center tailored” treatment pro-
tocol for CAPD peritonitis by examining the changes of
causative organisms and their susceptibilities to antimi-
crobial agents over the past 10 years.
♦ Method: Retrospective review of the medical records
of 1015 CAPD patients (1108 episodes of peritonitis) who
were followed up from 1992 through 2001.
♦ Results: The overall incidence of peritonitis was
0.40 episodes/patient-year. The annual rate of peritonitis
and the incidence of peritonitis caused by a single gram-
positive organism were significantly higher in 1992 and
1993 compared with those in the rest of the years (p <
0.05). The incidence of peritonitis due to coagulase-nega-
tive staphylococcus (CoNS) decreased significantly over
time, whereas there was no significant change in the inci-
dence of Staphylococcus aureus (SA)-induced peritoni-
tis. Among CoNS, resistance to methicillin increased from
18.4% in 1992 – 1993 to 41.7% in 2000 – 2001 (p < 0.05). In
contrast, the incidence of methicillin-resistant SA was not
different according to the calendar year. Catheter removal
rates were significantly higher in peritonitis due to a single
gram-negative organism (16.6%) compared with gram-
positive peritonitis (4.8%, p < 0.005). The mortality asso-
ciated with peritonitis was also higher in gram-negative
(3.7%) compared with gram-positive peritonitis (1.4%), but
there was no statistical significance. Among single gram-
positive organism-induced peritonitis, catheter removal
rates were significantly higher in SA (9.3%) than those in
CoNS (2.9%, p < 0.01) and other gram-positive organisms
(2.9%, p < 0.05). In peritonitis caused by CoNS, the meth-
icillin-resistant group showed significantly higher removal
rates than the methicillin-susceptible group (8.2% vs 1.0%,
p < 0.01).
♦ Conclusion: The incidence of peritonitis for 2001 de-
creased to less than half that for 1992, due mainly to a
significant decrease in CoNS-induced peritonitis, whereas
the proportions of peritonitis due to a single gram-nega-
tive organism and methicillin-resistant CoNS increased.
These findings suggest that it is necessary to prepare
new center-based guidelines for the initial empirical treat-
ment of CAPD peritonitis.
Perit Dial Int 2004; 24:424–432 www.PDIConnect.com
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Peritonitis is not only a common complication inend-stage renal disease (ESRD) patients treated
with continuous ambulatory peritoneal dialysis
(CAPD), but also is the leading cause of transfer to
hemodialysis (1–4). Although the incidence of perito-
nitis varies from center to center, it decreased dra-
matically in the 1990s to 1 episode/24 patient-months
(5–8).
The development of disconnect systems has sig-
nificantly reduced the overall incidence of peritonitis
(6–10), especially those caused by coagulase-negative
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staphylococcus (CoNS), the major organism respon-
sible for touch contamination. However, the incidence
of peritonitis caused by gram-negative organisms re-
mains at a steady level; therefore, their proportion
has increased relatively (11–14).
The character of a causative organism is an im-
portant determinant of clinical outcome (12,15–17).
Widely used treatment guidelines have continually
been modified by the International Society for Peri-
toneal Dialysis (ISPD), the most recent modification
being made in 2000 (18). Treatment guidelines should
be changed depending on the causative organisms
because empirical antimicrobial regimens for perito-
nitis are established by the major causative organ-
isms. Even though cross-sectional studies on the
causative organisms of peritonitis have been reported
frequently, long-term studies on changes in the caus-
ative organisms of peritonitis are scarce (11,12). There
has been only one study, conducted at a single center,
that analyzed the changes in infecting pathogens and
also their antimicrobial sensitivities (13).
In the present study, we investigated the causative
organisms, antimicrobial susceptibility, and catheter
removal rates relative to the causative organisms in
1015 CAPD patients with peritonitis, who were fol-
lowed up at Severance Hospital, Seoul, between 1992
and 2001. Yearly changes in the causative organisms
and antimicrobial susceptibility of each causative or-
ganism were also examined.
METHODS
This retrospective study was conducted with the
medical records of 1015 CAPD patients who were fol-
lowed up from January 1992 to December 2001 at
Severance Hospital, Yonsei University College of
Medicine, Seoul, Korea. All the patients were on CAPD
with a double-cuffed, straight Tenckhoff catheter.
Catheters were placed by a nephrologist, using a
Tenckhoff trocar, at the lateral border of the rectus
muscle; the skin exit was made at the counterpoint of
the catheter insertion site in a downward direction.
After catheter placement, intraperitoneal cefazolin for
3 days was routinely used.
The data recorded included age at time of perito-
nitis, age at start of CAPD, sex, cause of ESRD, caus-
ative organisms of peritonitis, antimicrobial
susceptibility of each organism, and date of catheter
removal. Patients were classified as having peritoni-
tis if they satisfied at least two of the following crite-
ria (6): (1) presence of clinical symptoms (pain, fever,
cloudy dialysate); (2) presence of more than 100 leuko-
cytes/mm3 dialysate, with at least 50% polymorpho-
nuclear neutrophils; and (3) positive culture or Gram
stain. An episode of peritonitis within 4 weeks after
the treatment of a previous episode was considered a
relapse and was not classified as a new infection. In
addition, a peritonitis episode within 7 days after cath-
eter placement was also excluded.
Since November 1993, culture of the dialysate has
been performed as recommended by the ISPD (19).
Whole dialysate (50 mL) is concentrated by centrifu-
gation, resuspended in sterile saline, inoculated into
blood culture media, and observed for at least 72 hours
to document pathogens. Antimicrobial susceptibility
is determined by standard disk-diffusion method.
For the present study, the causative organisms of
peritonitis were divided into gram-positive organisms
(Staphylococcus aureus, CoNS, Streptococcus, and En-
terococcus), gram-negative organisms (Escherichia
coli, Pseudomonas aeruginosa, other Pseudomonas
spp, Acinetobacter, Serratia, Klebsiella, Enterobacter,
and other gram-negative organisms), multi-organ-
isms, fungi, Mycobacterium tuberculosis, and culture
negative.
The numbers and rates of peritonitis were calcu-
lated per year of the entire study period. The numbers,
incidences, and proportions of peritonitis due to gram-
positive organisms, gram-negative organisms, multi-
organisms, fungi, M. tuberculosis, and culture-negative
peritonitis in each year were quantified. In addition,
the numbers, incidences, and proportions of peritoni-
tis caused by gram-positive organisms and gram-nega-
tive organisms were analyzed according to the duration
of CAPD before the onset of peritonitis: 1 – 6 months,
7 – 12 months, 13 – 18 months, 19 – 24 months, 25 –
36 months, 37 – 48 months, 49 – 60 months, 61 –
72 months, 73 – 96 months, and ≥ 97 months.
Among gram-positive organisms, S. aureus was
divided into methicillin-susceptible S. aureus (MSSA)
and methicillin-resistant S. aureus (MRSA) groups;
CoNS was also divided into methicillin-susceptible
and -resistant groups. The numbers, incidences, and
proportions of peritonitis caused by each group were
then compared for every 2 years of the 10-year study
period. Enterococcus species were divided into
E. faecalis and E. faecium, and their susceptibilities
to ampicillin and vancomycin were investigated.
Gram-negative organisms were divided into E. coli,
P. aeruginosa, and other gram-negative organisms,
and the antimicrobial susceptibilities to aminoglyco-
side (tobramycin, gentamicin, and amikacin), quino-
lone, and imipenem were analyzed for each organism.
When peritonitis was diagnosed, empirical therapy
with a combination of cefazolin and tobramycin was
initiated. Within 72 hours, the empirical antibiotics
were adjusted based on the results of the dialysate
culture and antimicrobial susceptibility test. In cul-
ture-negative peritonitis with no response to initial
therapy after 72 hours, cefazolin and tobramycin were
substituted by vancomycin and amikacin. If peritoni-
tis did not respond to adequate antibiotics after
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96 hours, the catheter was removed. In addition, the
catheter was removed in cases of frequent relapsing
peritonitis, fungal peritonitis, and tuberculous
peritonitis.
The catheter removal rates in peritonitis were cal-
culated according to the causative organisms: gram-
positive organisms, gram-negative organisms, fungi,
M. tuberculosis, and culture negative. In addition, the
catheter removal rates were compared for each or-
ganism according to its antimicrobial susceptibility.
STATISTICAL ANALYSIS
Data are expressed as episodes/patient-year, per-
cent, and mean ± standard deviation (SD). The inci-
dence of peritonitis was compared using the Poisson
regression model (20). Differences in the proportion
of causative organisms were analyzed according to
each calendar year. Antimicrobial susceptibilities and
catheter removal rates according to the pathogens
were analyzed using chi-square analysis or Fischer’s
exact test. Statistical significance was determined as
p value less than 0.05.
RESULTS
DEMOGRAPHIC AND CLINICAL CHARACTERISTICS
OF PATIENTS (TABLE 1)
Of the 1015 patients examined, 537 were men and
478 were women, their mean age at the initiation of
CAPD was 50.7 ± 13.6 years, and they were followed
up for a mean period of 3.3 ± 2.6 years. The causes of
ESRD are listed in Table 1.
CAUSATIVE ORGANISMS OF PERITONITIS
A total of 1108 episodes of peritonitis were re-
corded during this 10-year study period. The caus-
ative organisms of peritonitis are listed in Table 2.
Single gram-positive organisms caused 498 episodes
of peritonitis (44.9%), single gram-negative organ-
isms caused 163 episodes (14.7%), multi-organisms
caused 13 episodes (1.2%), fungi caused 24 episodes
(2.2%), and M. tuberculosis caused 1 episode (0.1%).
There were 409 episodes (36.9%) of culture-negative
peritonitis. When culture-negative episodes were
excluded, the most cases (71.2%) of peritonitis were
caused by a single gram-positive organism: 39.9%
by CoNS, 21.6% by S. aureus, 7.9% by Streptococ-
cus, and 1.9% by Enterococcus. Single gram-nega-
tive organisms accounted for 23.3% of culture-
positive peritonitis: E. coli in 8.6%, P. aeruginosa in
4.6%, other Pseudomonas spp in 0.7%, Acinetobacter
in 2.6%, Klebsiella in 1.9%, Serratia in 1.3%,
Enterobacter in 1.1%, and other gram-negative or-
ganisms in 2.6%.
PERITONITIS RATES AND CAUSATIVE ORGANISMS
ACCORDING TO EACH CALENDAR YEAR
The overall incidence of peritonitis during the
10-year study period was 0.40 episodes/patient-year.
When the incidence of peritonitis was analyzed ac-
cording to each calendar year, it was significantly
decreased (to < 0.40 episodes/patient-year) after 1998.
Compared with 1992 and 1993, the incidence of peri-
tonitis due to a single gram-positive organism de-
creased significantly after 1994 (p < 0.05), whereas
that of gram-negative peritonitis increased, result-
ing in a significant increase in the proportion of gram-
negative peritonitis after 1994 (p < 0.05) (Table 3 and
Figure 1). This decrease in the incidence of peritoni-
TABLE 2
Causative Organisms of CAPD Peritonitis (n = 699)
Organisms N (%)
Gram positives 498 (71.2)
CoNS 279 (39.9)
Staphylococcus aureus 151 (21.6)
Streptococcus sp 55 (7.9)
Enterococcus sp 13 (1.9)
Gram negatives 163 (23.3)
Escherichia coli 60 (8.6)
Pseudomonas aeruginosa 32 (4.6)
Other Pseudomonas species 5 (0.7)
Acinetobacter sp 18 (2.6)
Klebsiella sp 13 (1.9)
Serratia sp 9 (1.3)
Enterobacter sp 8 (1.1)
Other gram negatives 18 (2.6)
Multi-organism 13 (1.9)
Fungi 24 (3.4)
Mycobacterium tuberculosis 1 (0.1)
CoNS = coagulase-negative staphylococcus.
TABLE 1
Clinical Characteristics of Patients
Patients (n) 1015
Sex (male:female) 537:478
Age (years) 50.7±13.6a
Mean duration of follow-up (years) 3.3±2.6
Underlying disease [n (%)]
Chronic glomerulonephritis 328 (32.3)
Diabetes mellitus 326 (32.1)
Hypertension 149 (14.7)
Polycystic kidney disease 24 (2.4)
Systemic lupus erythematosus 12 (1.2)
Others or unknown 176 (17.3)
a Mean ± standard deviation.
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TABLE 3
Incidences and Causative Organisms of CAPD Peritonitis from 1992 to 2001
Year 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001
CAPD patients (n) 203 265 324 347 395 432 466 506 495 498
Mean age (years) 49.0 48.9 49.1 50.2 51.5 52.7 53.7 55.0 56.0 56.2
Patients on double bag (%) 36.9 62.3 91.0 95.1 97.5 97.7 98.7 98.8 98.8 99.0
Diabetics (%) 25.6 22.6 22.2 22.8 22.8 24.0 24.4 27.2 27.0 26.1
Peritonitis episodes (n) 81 86 97 121 152 129 125 136 95 86
Incidence (episodes/patient-year) 0.49 0.50 0.48 0.42 0.45 0.45 0.34 0.35 0.25 0.23
Culture negative [n (%)] 26 (32.1) 23 (26.7) 27 (27.8) 54 (44.6) 71 (46.7) 37 (28.7) 45 (36.0) 56 (41.2) 38 (40.0) 32 (37.2)
Organisms [n (%)]
Gram positive 48 (87.3) 56 (88.9) 47 (67.1) 46 (68.7) 59 (72.8) 63 (68.5) 50 (62.5) 49 (61.3) 42 (73.7) 38 (70.4)
Gram negative 4 (7.3) 6 (9.5) 17 (24.3) 16 (23.9) 19 (23.5) 22 (23.9) 23 (28.8) 29 (36.3) 12 (21.1) 15 (27.8)
Multi-organism 2 (3.6) 0 (0) 2 (2.9) 1 (1.5) 2 (2.5) 2 (2.2) 2 (2.5) 0 (0) 1 (1.8) 1 (1.9)
Fungi 1 (1.8) 1 (1.6) 3 (4.3) 4 (6.0) 1 (1.2) 5 (5.4) 5 (6.3) 2 (2.5) 2 (3.5) 0 (0)
Mycobacterium tuberculosis 0 (0) 0 (0) 1 (1.4) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
Total 55 (100) 63 (100) 70 (100) 67 (100) 81 (100) 92 (100) 80 (100) 80 (100) 57 (100) 54 (100)
tis due to a single gram-positive organism was due
mainly to a significant decrease in CoNS-induced
peritonitis. The incidence of CoNS-induced peritoni-
tis decreased from 0.226 episodes/patient-year in
1992 – 1993 to 0.064 episodes/patient-year in 2000 –
2001. On the other hand, the incidence of peritonitis
due to S. aureus remained at a steady level. There
was also a significant decrease in the proportion of
peritonitis caused by CoNS after 1994 compared with
1992 – 1993 (p < 0.01) (Figure 2).
When the causative organisms of peritonitis were
analyzed according to duration of CAPD before the
onset of peritonitis, there was no difference in the
incidence of peritonitis between gram-positive and
gram-negative organisms (data not shown).
ANTIMICROBIAL SUSCEPTIBILITY OF GRAM-
POSITIVE ORGANISMS
Coagulase-Negative Staphylococcus: Of the 279 epi-
sodes of peritonitis caused by CoNS, 206 (73.8%) were
caused by methicillin-sensitive (MS-) CoNS and 73
(26.2%) by methicillin-resistant (MR-) CoNS. The in-
cidence of peritonitis due to MS-CoNS showed a
steady decrease over time (0.184, 0.082, 0.070, 0.042,
Figure 2 — The proportions and incidences of peritonitis
due to coagulase-negative staphylococcus (CoNS) (propor-
tion: shaded bars; incidence: closed circles) and Staphylo-
coccus aureus (proportion: white bars; incidence: open
circles). The incidence of CoNS-induced peritonitis de-
creased from 0.226 episodes/patient-year in 1992 – 1993 to
0.064 episodes/patient-year in 2000 – 2001. On the other
hand, the incidence of peritonitis due to S. aureus remained
at a steady level. There was also a significant decrease in
the proportion of peritonitis caused by CoNS after 1994
compared with 1992 – 1993. *p < 0.01 versus 1992 – 1993.
Figure 1 — The proportions and incidences of peritonitis
due to a single gram-positive (proportion: shaded bars; in-
cidence: closed circles) and a single gram-negative organ-
ism (proportion: white bars; incidence: open circles).
Compared with 1992 – 1993, the incidence of peritonitis
due to a single gram-positive organism decreased signifi-
cantly after 1994, whereas that of gram-negative peritoni-
tis increased, resulting in a significant increase in the
proportion of gram-negative peritonitis after 1994. *p < 0.05
versus 1992 – 1993.
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and 0.037 episodes/patient-year in 1992 – 1993,
1994 – 1995, 1996 – 1997, 1998 – 1999, and 2000 –
2001, respectively), whereas that of MR-CoNS-
induced peritonitis remained at a constant level, re-
sulting in a significant increase in the proportion of
peritonitis due to MR-CoNS after 1998 (p < 0.05) (Fig-
ure 3).
Staphylococcus aureus: Staphylococcus aureus was
the etiologic agent in 151 episodes of peritonitis; 35.1%
showed resistance to methicillin (MRSA). There was
no difference in the incidence of peritonitis due to
MSSA and MRSA by calendar year (Figure 4).
Enterococcus: Enterococcus species were respon-
sible for 13 episodes of peritonitis: 6 (46.2%) were
caused by E. faecalis and 7 (53.8%) by E. faecium. All
E. faecalis showed sensitivity to ampicillin, whereas
all E. faecium were resistant to ampicillin. Vancomy-
cin-resistant enterococcus was isolated in 1 of 13 epi-
sodes (7.7%). There was no significant change in the
incidence of peritonitis due to Enterococcus spp dur-
ing the study period (data not shown).
ANTIMICROBIAL SUSCEPTIBILITIES OF GRAM-
NEGATIVE ORGANISMS
There was no difference among E. coli, P. aerugino-
sa, and other gram-negative organisms in their sus-
ceptibility to aminoglycosides, including tobramycin,
gentamicin, and amikacin. Although the susceptibili-
ties of E. coli and P. aeruginosa to quinolone were not
different, they were significantly lower than those of
other gram-negative organisms (p < 0.05) (Table 4).
All gram-negative organisms showed sensitivity to
imipenem since 1993, when imipenem was introduced
for sensitivity testing. There was no significant change
in the antimicrobial susceptibility of gram-negative
organisms during the study period (data not shown).
OUTCOME (TABLE 5)
In 109 (9.8%) of 1108 episodes of peritonitis, the
patients were transferred to hemodialysis following
removal of the peritoneal catheter. Among those
109 patients, 19 returned to CAPD after complete
resolution of peritonitis, 66 remained on hemodialy-
sis, and 24 patients died of peritonitis-associated com-
plications. Catheter removal rates were significantly
higher in peritonitis due to a single gram-negative
organism (27/163, 16.6%) compared with gram-posi-
tive peritonitis (24/498, 4.8%) (p < 0.005). Mortality
associated with peritonitis was also higher in gram-
negative (6/163, 3.7%) compared with gram-positive
peritonitis (7/498, 1.4%), but there was no statistical
significance.
Gram-Positive Peritonitis: Among episodes due to
a single gram-positive organism, catheter removal
rates were significantly higher in those due to
S. aureus (14/151, 9.3%) compared with those due to
CoNS (8/279, 2.9%) (p < 0.01) and other gram-posi-
tive organisms (2/68, 2.9%) (p < 0.05). In contrast,
there was no statistically significant difference in
peritonitis-related mortality between those three
groups.
Figure 4 — The proportions and incidences of peritonitis
due to methicillin-sensitive Staphylococcus aureus (MSSA)
(proportion: shaded bars; incidence: closed circles) and
methicillin-resistant SA (MRSA) (proportion: white bars;
incidence: open circles). There was no difference in the in-
cidences and proportions of peritonitis due to MSSA and
MRSA by calendar year.
Figure 3 — The proportions and incidences of peritonitis
due to methicillin-sensitive coagulase-negative staphylo-
coccus (MS-CoNS) (proportion: shaded bars; incidence:
closed circles) and methicillin-resistant (MR-) CoNS (pro-
portion: white bars; incidence: open circles). The incidence
of MS-CoNS-induced peritonitis showed a steady decrease
over time (from 0.184 episodes/patient-year in 1992 – 1993
to 0.037 episodes/patient-year in 2000 – 2001), whereas that
of MR-CoNS-induced peritonitis remained at a constant
level, resulting in a significant increase in the proportion
of peritonitis due to MR-CoNS after 1998. *p < 0.05 versus
1992 – 1993, 1994 – 1995, and 1996 – 1997; #p < 0.01 ver-
sus 1992 – 1993, 1994  – 1995, and 1996  – 1997.
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When catheter removal rates were compared ac-
cording to antimicrobial susceptibility in CoNS, they
were significantly higher in the MR group (6/73, 8.2%)
compared with the MS group (2/206, 1.0%) (p < 0.01).
In contrast, there was no statistical difference between
MRSA (8/98, 8.2%) and MSSA (6/53, 11.3%).
Gram-Negative Peritonitis: Among 163 episodes of
peritonitis due to a single gram-negative organism,
the peritoneal catheter was removed in 27 episodes
(16.6%). Catheter removal rates were significantly
higher in peritonitis due to P. aeruginosa (14/32,
43.8%) compared with those due to E. coli (3/60, 5.0%)
(p < 0.005) or other gram-negative organisms (10/71,
14.1%) (p < 0.01). Mortality associated with Klebsiella-
induced peritonitis was the highest (2/13, 15.4%)
among the gram-negative peritonitis, but there was
no significant difference in mortality according to
causative organisms.
Fungal and Tuberculous Peritonitis: In all episodes
of fungal and the 1 episode of tuberculous peritoni-
tis, the peritoneal catheter was removed. Mortality
related to fungal peritonitis was significantly higher
(7/24, 29.2%) compared with that associated with
gram-positive (7/498, 1.4%) (p < 0.001), gram-nega-
tive (6/163, 3.7%) (p < 0.001), and culture-negative
peritonitis (3/409, 0.7%) (p < 0.001).
Culture-Negative Peritonitis: Among the 409 epi-
sodes of culture-negative peritonitis, 307 episodes
(75.1%) responded to the empirical antibiotics,
cefazolin and tobramycin, and 73 episodes (17.8%) to
the second-line drugs, vancomycin and amikacin. The
peritoneal catheter was removed in 29 episodes (7.1%)
of culture-negative peritonitis because of no clinical
improvement.
DISCUSSION
To the best of our knowledge, this is the first study
investigating changes in the causative organisms of
peritonitis and their antimicrobial susceptibilities in
more than 1000 CAPD patients, and during 10 years
at a single center.
In the 1990s, the incidence of peritonitis decreased
significantly, to 1 episode/24 patient-months. This
change was due to improvement in connect systems,
development of new dialysis solutions, improvements
in living environments, and education of patients
(5–8). In the present study, we also found a decreased
incidence of peritonitis from 1992 to 2001, in which
the incidence was 0.23 episodes/patient-year, being
less than 50% of the 0.49 episodes/patient-year in
1992. Considering the fact that the double-bag sys-
tem was introduced in the Severance Hospital in the
early 1990s, and about 35% of our patients were on
the double-bag system in 1992 and more than 95%
after 1995, the decrease in the incidence of peritoni-
tis due to a single gram-positive organism, especially
CoNS, between 1992 and 1994 might have resulted
from the new connect system. However, even after
extensive usage of the double-bag system, the inci-
dence of peritonitis decreased steadily.
TABLE 4
Antimicrobial Susceptibilities of Gram-Negative Organisms
Susceptibility (%)
Tobramycin Gentamicin Amikacin Quinolone
Organisms Isolates (n) S R S R S R S R
Escherichia coli 60 91.7 8.3 78.3 21.7 98.3 1.7 90.0 10.0
Pseudomonas aeruginosa 32 84.4 15.6 87.5 12.5 93.8 6.2 90.6 9.4
Other gram negatives 71 88.7 11.3 90.1 9.9 91.5 8.5 100 0a
S = susceptible; R = resistant.
a p < 0.05 versus E. coli and P. aeruginosa.
TABLE 5
Catheter Removal and Peritonitis-Associated
Death According to Causative Organism
Isolates Removals Deaths
Organism (n) [n (%)] [n (%)]
Gram positives 498 24 (4.8) 7 (1.4)
Staphylococcus aureus 151 14 (9.3) 4 (2.7)
CoNS 279 8 (2.9) 2 (0.7)
Streptococcus sp 55 1 (1.8) 1 (1.8)
Enterococcus sp 13 1 (7.7) 1 (7.7)
Gram negatives 163 27 (16.6) 6 (3.7)
Pseudomonas aeruginosa 32 14 (43.8) 2 (6.3)
Escherichia coli 60 3 (5.0) 1 (1.7)
Serratia sp 9 3 (33.3) 0 (0.0)
Klebsiella sp 13 3 (23.1) 2 (15.4)
Enterobacter sp 8 1 (12.5) 1 (12.5)
Other gram negative 41 3 (7.3) 0 (0.0)
Multi-organism 13 4 (30.8) 1 (7.6)
Fungi 24 24 (100) 7 (29.2)
Mycobacterium tuberculosis 1 1 (100) 0 (0.0)
Culture negative 409 29 (7.1) 3 (0.7)
Total 1108 109 (9.8) 24 (2.2)
CoNS = coagulase-negative staphylococcus.
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It has been shown that the incidence of peritonitis
differs according to patient demographics, such as race
(21–23) and age (24,25), mode of PD (CAPD vs auto-
mated PD) (26), and composition of dialysis solutions
(27). In the present study, all the subjects were
Korean, and there was a small increase in the pro-
portion of diabetics and the age of patients after 1995.
In addition, all the patients included in this study
were on CAPD and used conventional lactate-based
solution. Therefore, we are inclined to believe that
the specially trained nurses in our PD unit, who par-
ticipated in training new CAPD patients and in edu-
cating patients who visited our PD unit due to
peritonitis, and the patient education program, which
has been in operation since 1995, contributed to this
decrease. Our education program for new CAPD pa-
tients consists of 1 hour for 2 days. On the first day,
patients learn the basic physiology of PD and how to
exchange dialysate; on the second day, they learn PD
complications and how to deal with these problems.
The use of intraperitoneal antibiotics is a standard
treatment of peritonitis; initial empirical antibiotics
are determined by the major organisms responsible
for peritonitis. Based on differences in the epidemiol-
ogy of the causative organisms and in their antimi-
crobial susceptibilities, many investigators (28,29)
suggest that individual centers should continuously
monitor the epidemiology of CAPD peritonitis, and
that the management of peritonitis should be adapted
to the local situation in a “center tailored” treatment
protocol. Nevertheless, only a few studies have at-
tempted to examine the epidemiology of the causative
organisms and their antimicrobial susceptibilities
(28,30–32), and there has been only one report at a
single center on changes in antimicrobial suscepti-
bility according to each organism (13).
Among gram-positive organisms, we found that the
incidence and the proportion of peritonitis due to
MRSA had increased during 1992 and 1997; however,
they deceased to levels similar to 1992 – 1993. On
the other hand, the proportion of peritonitis due to
MR-CoNS, which is the most common causative or-
ganism of CAPD peritonitis, has been on the rise
steadily since 1992. An increase in MR S. epidermidis,
which is often resistant to multiple antibiotics, from
blood isolates has been reported (33). Zelenitsky et al.
(13) have also observed that, among S. epidermidis
peritonitis, resistance to methicillin increased from
18.9% in 1991 – 1992 to 73.9% in 1997 – 1998. In
addition, some authors recommend a switch from
cefazolin or cephalothin to vancomycin because treat-
ment of patients with an antibiotic showing very high
resistance was not warranted (31,32). In view of the
significant changes in the antimicrobial susceptibil-
ity of CoNS observed in our present study, we sug-
gest that the use of first-generation cephalosporin as
the initial empirical antibiotic, which has been rec-
ommended by the ISPD (18), should be limited.
There have been many studies on the effect of
S. aureus prophylaxis on the prevention of peritoni-
tis, but the results are controversial (34–36). In the
present study, we could not evaluate the effect of
S. aureus prophylaxis in our patients because it has
never been performed at our institute.
Similar to earlier studies (5,11–13,28,37), the pro-
portion of peritonitis due to E. coli and P. aeruginosa
among gram-negative organisms was found to be high.
In the present study, susceptibility to aminoglycosides,
which are used as the initial empirical antibiotic, was
not statistically different among E. coli, P. aeruginosa,
and other gram-negative organisms. However, E. coli
and P. aeruginosa showed relatively high resistance
to gentamicin and tobramycin respectively. Millikin
et al. (30) also found that only 48% of gram-negative
peritonitis responded to aminoglycoside monotherapy,
whereas 75% responded to combination regimens.
This relatively high resistance to aminoglycoside led
us to consider new center-based guidelines for the
treatment of peritonitis. In this study, we could not
evaluate susceptibility to ceftazidime, an antibiotic
recommended as an initial empirical drug by the ISPD
(18), because its susceptibility was routinely tested
only after mid-1990s, and the National Health Insur-
ance Corporation in Korea does not permit ceftazi-
dime as an empirical drug.
When clinical symptoms and signs do not improve
with appropriate intraperitoneal antibiotics, the cath-
eter should be removed and systemic antibiotics ad-
ministrated for at least 1 week. Catheter removal
rates were significantly lower in peritonitis due to a
single gram-positive organism than in those due to a
single gram-negative organism or fungus, a finding
consistent with previous studies (12,16,17). However,
among gram-positive organisms, catheter removal
rates in peritonitis due to MR-CoNS, which have been
increasing recently, were significantly higher than
MS-CoNS, thus we expect a gradual increase in cath-
eter removal rates in the future.
We experienced catheter removal rates similar to
those of Troidle et al. (16) in peritonitis due to a single
gram-negative organism. Peritonitis due to P. aerugin-
osa usually accompanies more severe symptoms and
does not respond well to antibiotics, resulting in high
catheter removal rates: up to 50% – 100% (30,38–40).
However, in the present study, we found a relatively
low catheter removal rate of 43.8%, due probably to
early and prolonged use of newly developed anti-
pseudomonas antibiotics, combination regimens, and
a well-designed patient education program. Taber
et al. (41) also observed that, of 7 patients with peri-
tonitis caused by Pseudomonas sp (aeruginosa,
fluorescens, stutszeri, and maltophilia), 5 patients
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were cured with the combination of ceftazidime and
ciprofloxacin, suggesting that a combination regimen
could result in a better response rate in pseudomo-
nas peritonitis.
It should be noted that we had a higher propor-
tion of culture-negative peritonitis in this study than
the generally accepted rate of 10% – 20% (7,13,37).
Even though it is difficult to explain the high inci-
dence in a retrospective study, it might have been
due partly to the use of intraperitoneal antibiotics
prior to visits to our PD unit. All the patients were
taught to bring the first cloudy dialysate, but com-
pliance was not good enough. This high proportion
of culture-negative peritonitis could lead to misin-
terpretation of the results. Therefore, to minimize
this confounding effect, we analyzed not only the
incidence but also the proportion of causative organ-
isms after excluding culture-negative peritonitis. Use
of antibiotic-removing or -neutralizing resin in these
cases could be an alternative to lower the rate of cul-
ture-negative peritonitis.
In conclusion, the incidence of peritonitis in 2001
is less than a half that of 1992, concomitant with an
increase in the proportion of peritonitis due to a single
gram-negative organism and MR-CoNS. Conse-
quently, it is necessary to prepare new center-based
treatment guidelines for CAPD peritonitis.
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